Mark Clemons
Impact in
- Oncology top 0.5%
- Bone health and treatments
- Cancer Diagnosis and Treatment
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer Research top 2%
- Breast Cancer Treatment Studies
Papers in
- Oncology 164
- Bone health and treatments 80
- Cancer Diagnosis and Treatment 54
- Cancer Treatment and Pharmacology 40
-
- Breast Cancer Treatment Studies 43
- Co-authors
- Brian HuttonGeorge DranitsarisSasha MazzarelloEitan AmirIryna KuchukLisa VandermeerDavid GianfeliceChristina Addison
- Journals
- Breast Cancer Research and Treatment (28 papers)Journal of Clinical Oncology (25 papers)Supportive Care in Cancer (22 papers)Cancer Treatment Reviews (10 papers)Annals of Oncology (6 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Mark Clemons
213 papers receiving 5.2k citations
Peers
Comparison fields: 5 of 139
- Oncology 3.3k
- Cancer Research 1.0k
- Pulmonary and Respiratory Medicine 1.3k
- Radiology, Nuclear Medicine and Imaging 899
- Orthopedics and Sports Medicine 269
Countries citing papers authored by Mark Clemons
This map shows the geographic impact of Mark Clemons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Clemons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Clemons more than expected).
Fields of papers citing papers by Mark Clemons
This network shows the impact of papers produced by Mark Clemons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Clemons. The network helps show where Mark Clemons may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark Clemons, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2023 | 1 | |
| 3 | 2022 | 0 | |
| 4 | 2021 | 6 | |
| 5 | 2020 | 6 | |
| 6 | 2019 | 1 | |
| 7 | 2018 | 14 | |
| 8 | 2016 | 22 | |
| 9 | 2016 | 4 | |
| 10 | 2016 | 36 | |
| 11 | 2014 | 21 | |
| 12 | 2013 | 8 | |
| 13 | 2012 | 93 | |
| 14 | 2012 | 8 | |
| 15 | 2011 | 139 | |
| 16 | 2010 | 28 | |
| 17 | 2009 | 226 | |
| 18 | 2006 | 3 | |
| 19 | 2004 | 4 | |
| 20 | 1997 | 3 |
About Mark Clemons
Mark Clemons is a scholar working on Oncology, Cancer Research, Dermatology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine, having authored 218 papers that have together received 5.3k indexed citations. Recurring topics across this work include Bone health and treatments (80 papers), Cancer Diagnosis and Treatment (54 papers), Breast Cancer Treatment Studies (43 papers), Cancer Treatment and Pharmacology (40 papers), Radiopharmaceutical Chemistry and Applications (36 papers), Management of metastatic bone disease (26 papers), Chemotherapy-related skin toxicity (19 papers) and Medical Imaging and Pathology Studies (19 papers). The work is most often cited by research in Oncology (3.3k citations), Cancer Research (1.0k citations), Pulmonary and Respiratory Medicine (1.3k citations), Radiology, Nuclear Medicine and Imaging (899 citations) and Orthopedics and Sports Medicine (269 citations). Mark Clemons has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Brian Hutton, George Dranitsaris, Sasha Mazzarello, Eitan Amir, Iryna Kuchuk, Lisa Vandermeer, David Gianfelice, Christina Addison, Sunil Verma and Paul Wheatley‐Price. Their work appears in journals such as Breast Cancer Research and Treatment, Journal of Clinical Oncology, Supportive Care in Cancer, Cancer Treatment Reviews and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.